Percheron Therapeutics (ASX:PER) warned shareholders about an unauthorized letter and pre-filled proxy form sent by requisitioning shareholder Powerhouse Ventures ahead of its April 24 general meeting, according to a Tuesday filing with the Australian bourse.
The documents, which falsely appeared to be from Percheron, directly reply to an unknown third party not approved to handle proxies, the filing said.
The company urged shareholders to submit forms directly to its registry, Boardroom, to ensure validity.
Shares of the company fell 17% in recent Tuesday trade
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.